2-174753570-G-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PS1PM2PP2PP3PP5_Moderate
The NM_000079.4(CHRNA1):c.711C>A(p.Asn237Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N237I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000079.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 1AInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- myasthenic syndrome, congenital, 1B, fast-channelInheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA1 | NM_000079.4 | c.711C>A | p.Asn237Lys | missense_variant | Exon 6 of 9 | ENST00000348749.9 | NP_000070.1 | |
| CHRNA1 | NM_001039523.3 | c.786C>A | p.Asn262Lys | missense_variant | Exon 7 of 10 | NP_001034612.1 | ||
| CHRNA1 | XM_017003256.2 | c.807C>A | p.Asn269Lys | missense_variant | Exon 6 of 9 | XP_016858745.1 | ||
| CHRNA1 | XM_017003257.2 | c.732C>A | p.Asn244Lys | missense_variant | Exon 5 of 8 | XP_016858746.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Lethal multiple pterygium syndrome Pathogenic:1
This missense change has been reported to affect CHRNA1 protein function (PMID: 8872460). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This missense change has been observed in individuals affected with autosomal dominant congenital myasthenic syndrome (PMID: 29395675, 8872460). This variant is also known as N217K in the literature. ClinVar contains an entry for this variant (Variation ID: 466184). This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with lysine at codon 237 of the CHRNA1 protein (p.Asn237Lys). The asparagine residue is highly conserved and there is a moderate physicochemical difference between asparagine and lysine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at